Aurlumyn™ (iloprost) – New orphan drug approval
February 14, 2024 - The FDA announced the approval of Eicos Sciences’ Aurlumyn (iloprost), for the treatment of severe frostbite in adults to reduce the risk of digit amputations.
February 14, 2024 - The FDA announced the approval of Eicos Sciences’ Aurlumyn (iloprost), for the treatment of severe frostbite in adults to reduce the risk of digit amputations.